PREDICTIVE FACTORS FOR REGIONAL LYMPH NODE INVOLVEMENT IN EARLY GASTRIC CANCER PATIENTS

  • Aljaž Repše Klinični oddelek za gastroenterologijo Interna klinika Klinični center Japljeva 2 1525 Ljubljana
Keywords: gastric cancer, early, regional lymph node involvement, endoscopic treatment

Abstract

Background. Number of endoscopically treated early gastric cancer (EGC) patients has been constantly growing. EMR is relatively simple, unexpensive, has low complication rate and offers substantially better quality of life than classical operative therapy.

Patients and methods. 158 EGC patients were treated in Clinical centre Ljubljana from Jan. 1st 1983 to Dec. 31st 1997; 156 patients were operated on, 2 were treated endoscopically. Importance of several clinico-pathological predictive factors for lymph node involvement was first tested by chi-square test and then included in multivariate model.

Results. 24 out of 156 (15.4%) resected patients had positive regional lymph nodes. Multivariate analysis proved the importance of depth of infiltration (p = 0.0005), of histological type by Lauren (p = 0.0087) and partly of the size of the lesion (p = 0.1355) as prognostic factors for regional lymph node involvement. Relative risk in submucosal EGC is 7.4 times greater than that in mucosal EGC. Diffuse type has 4.5 times and mixed 5.2 times the risk in intestinal type. Each cm in diameter increased the relative risk 1.2 times. Observed 5-year survival of our patients was 81.7% (85.7% in N0 and 53.3% in N+ patients).

Conclusions. EMR is the treatment of choice in patients with early gastric cancer and no regional lymph node metastases. Proper selection of patients by clinico-pathological predictive factors for regional lymph node metastases is essential. Beside two endoscopically treated patients, 12 patients were suitable for such a therapeutic procedure in our 15-year series.

Downloads

Download data is not yet available.

References

Hioki K, Nakane Y, Yamamoto M. Surgical strategy for early gastric cancer. Br J Surg 1990; 77: 1330–4.

Sawai K, Takahashi T, Suzuki H. New trends in surgery for gastric cancer in Japan. J Surg Onc 1994; 56: 221–6.

Yamashita Y, Kurohiji T, Kakegawa T, Bekki F, Ogata M. Laparoscopyguided extracorporeal resection of early gastric carcinoma. Endoscopy 1995; 27: 248–52.

Lambert R. Endoscopic therapy of esophago-gastric tumors. Endoscopy 1992: 24: 24–33.

Fleischer DE. Concluding Remarks: Endoscopic resection of gastrointestinal tumors. Endoscopy 1993; 25: 479–81.

Tada M, Murakami A, Karita M, Yanai H, Okita K. Endoscopic resection of early gastric cancer. Endoscopy 1993; 25: 445–50.

Fujii M, Sasaki J, Nakajima T. State of the art in the treatment of gastric cancer: from the 71st Japanese Gastric Cancer Congress. Gastric Cancer 1999; 2: 151–7.

Korenaga D, Orita H, Maekawa S, Maruoka A, Sakai K, Ikeda T, Sugimachi K. Pathological appearance of the stomach after endoscopic mucosal resection for early gastric cancer. Br J Surg 1997; 84: 1563–6.

Kashimura H, Ajioka Y, Watanabe H, Nishikura K, Iiri T, Asakura H. Risk factors for nodal micrometastasis of submucosal gastric carcinoma: assessment of indications for endoscopic treatment. Gastric Cancer 1999; 2: 33–9.

Kakeji Y, Maehara Y, Shibahara K, Hasuda S, Tokunaga E, Oki Eiji, Sugimachi K. Clinical significance of micrometastasis in bone marrow of patients with gastric cancer and its relation to angiogenesis. Gastric Cancer 1999; 2: 46– 51.

Akahoshi K, Chijiiwa Y, Hamada S, Sasaki I, Maruoka A, Kabemura T, Nawata H. Endoscopic ultrasonography: A promising method for assessing the prospects of endoscopic mucosal resection in early gastric cancer. Endoscopy 1997; 29: 614–9.

Nakajima T, Ochiai T, Ogawa M et al. Meeting report of the 71st Japanese Gastric Cancer Congress. Gastric Cancer 1999; 2: 145–50.

Yamao T, Shirao K, Ono H et al. Risk factors for lymph node metastasis from intramucosal gastric carcinoma. Cancer 1996; 77: 602–6.

Habu H, Takeshita K, Sunagawa M, Endo M. Lymph node metastasis in early gastric cancer. Int Surg 1986; 71: 244–7.

Maehara Y, Orita H, Okuyama T, Moriguchi S, Tsujitani S, Korenaga D, Sugimachi K. Predictors of lymph node metastasis in early gastric cancer. Br J Surg 1992; 79: 245–7.

Noda M, Kodama T, Atsumi M, Nakajima M, Sawai N, Kashima K, Pignatelli M. Possibilities and limitations of endoscopic resection for early gastric cancer. Endoscopy 1997; 29: 361–5.

Takakoshi T, Baba Y, Ota H, Kato Y, Yangisawa A, Takagi K, Noguchi Y. Endoscopic resection of early gastric carcinoma: results of retrospective analysis of 308 cases. Endoscopy 1994; 26: 352–8.

Mazzeo F, Mozzillo N, Forestieri P. Cancer of the stomach. In: Veronesi U ed. Surgical oncology. Berlin, Heidelberg, New York: Springer, 1989: 544–77.

Frentzel-Beyne R, Boing H. Magenkrebs – Epidemiologie. In: Gall FP, Hermanek P, Hornig D eds. Magenkarzinom. Epidemiologie, Pathologie, Therapie, Nachsorge. München: Zuckschwerdt W, 1986: 1–17.

Hayes N, Karat D, Scott DJ, Raimes SA, Griffin SM. Radical lymphadenectomy in the management of early gastric cancer. Br J Surg 1996; 83: 1421–3.

Siewert JR, Kestlmeier R, Busch R, Böttcher K, Roder JD, Müller J, Fellbaum C, Höfler H. Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg 1996; 83: 1144–7.

Fujimori T, Nakamura T, Hirayama D, Satonaka K et al. Endoscopic Mucosectomy for early gastric cancer using modified strip biopsy. Endoscopy 1992; 24: 187–9.

Takeshita K, Tani M, Inoue H et al. A new method of endoscopic mucosal resection of neoplastic lesions of the stomach: Its technical features and results. Hepato-gastroenterology 1997; 44: 1602–11.

Moreaux J, Bougaran J. Early gastric cancer. A 25-year surgical experience. Ann Surg 1993; 217: 347–55.

Guadagni S, Reed PI, Johnston BJ et al. Early gastric cancer: follow-up after gastrectomy in 159 patients. Br J Surg 1993; 80: 325–8.

Pertl A, Jagoditsch M, Jatzko GR, Denk H, Stettner HM. Long-term results of early gastric cancer accomplished in a European institution by Japanesetype radical resection. Gastric Cancer 1999; 2: 115–21.

Jähne J, Meyer HJ, Maschek H, Geerlings H, Bruns E, Pichlmayr R. Lymphadenectomy in gastric carcinoma. A prospective and prognostic study. Arch Surg 1992; 127: 290–4.

Maruyama M, Takeshita K, Endo M, Deakin M, Moossa AR. Clinicopathological study of gastric carcinoma in high- and low-mortality countries: Comparison between Japan and the United States. Gastric Cancer 1998; 1: 64–70.

Tachibana M, Takemoto Y, Monden N et al. Clinicopathological features of early gastric cancer: results of 100 cases from a Rural General Hospital. Eur J Surg 1999; 165: 319–25.

Bozzetti F, Bonfanti G, Mariani L, Miceli R, Andreola S. Risk of second malignancies after surgical treatment for early gastric cancer. Gastric Cancer 1999; 2: 74–5.

How to Cite
1.
Repše A. PREDICTIVE FACTORS FOR REGIONAL LYMPH NODE INVOLVEMENT IN EARLY GASTRIC CANCER PATIENTS. TEST ZdravVestn [Internet]. 1 [cited 5Aug.2024];71(10). Available from: http://vestnik-dev.szd.si/index.php/ZdravVest/article/view/1639
Section
Professional Article